Health Care

RIAD, Saudi-Arabien, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Das King Faisal Specialist Hospital and Research Centre (KFSHRC) hat an zwei aufeinanderfolgenden Tagen erfolgreich 10 Cross-Over-Nierentransplantationen durchgeführt und damit einen weltweiten Rekord für die meisten derartigen Eingriffe innerhalb von zwei Tagen in einem einzigen Zentrum aufgestellt – zeitgleich mit dem Weltorganspendetag am 13. August. Dieser Meilenstein unterstreicht die führende Rolle des KFSHRC im Bereich der Organtransplantation weltweit.

Ad hoc announcement pursuant to Art. 53 LR

Ad hoc-Mitteilung gemäss Art. 53 KR

Los Angeles, CA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (“BioSig” or the “Company”), which recently merged with Streamex Exchange Corporation (“Streamex”) (NASDAQ: BSGM), today announced the pricing of its previously announced underwritten public offering of 3,852,149 shares of common stock at a public offering price of $3.90 per share. The offering is expected to close on or around August 15, 2025 subject to customary closing conditions. The gross proceeds from the offering, before deducting underwriter discounts and commissions and other estimated offering expenses are expected to be approximately $15,023,381.10. BioSig intends to use the net proceeds from the offering to purchase gold bullion in accordance with its investment policy, for working capital and for general corporate purposes.

Woburn, MA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy in dermatology, today reported financial results for the three and six months ended June 30, 2025 and provided a business update.